The Higher Practice Podcast for Optimal Mental Health The Business of Psychedelic Therapy - Keith Kurlander & Will Van Derveer
Mar 27, 2023
AI Snips
Chapters
Transcript
Episode notes
Psychedelic Therapy Promise
- Psychedelic therapy shows promise for treatment-resistant depression and PTSD where traditional medications often fail.
- MDMA and psilocybin are leading candidates with early data showing substantial symptom relief.
Rethinking Treatment Foundations
- Psychedelic therapy isn't a cure-all but could have been a better foundation than antidepressants.
- Starting mental health treatment with psychedelic medicines might change the trajectory of care.
Durability of Psychedelic Benefits
- Benefits from MDMA and psilocybin therapies appear durable, lasting many months beyond treatment.
- Many patients potentially put chronic mental health disorders behind them for long-term recovery.